eFFECTOR Therapeutics (EFTR) Stock Chart & Stock Price History $0.0002 0.00 (-66.67%) As of 05/22/2025 10:09 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock eFFECTOR Therapeutics Stock Price Performance The eFFECTOR Therapeutics (EFTR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 99.99%, with a year-to-date return of 0.00%. In the past month, the stock has remained steady at 0.00%, reflecting recent market activity. As of the latest close, eFFECTOR Therapeutics traded at $0.00 with a market cap of $1,000.00 and volume of 212 shares. Receive EFTR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for eFFECTOR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-66.67%1 Month Performance0.00%3 Month Performance0.00%Year-To-Date Performance0.00%1 Year Performance-99.99% EFTR Stock Chart for Friday, May, 23, 2025 EFTR Chart by TradingView eFFECTOR Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/22/2025$0.00$0.00$0.00$0.00212 shs$1,000.0005/21/2025$0.00$0.00$0.00$0.0025,017 shs$1,000.0005/20/2025$0.00$0.00-66.67%$0.00$0.00206 shs$1,000.0005/19/2025$0.00$0.00$0.00$0.0061 shs$3,000.0005/16/2025$0.00$0.00$0.00$0.00326 shs$3,000.0005/15/2025$0.00$0.00$0.00$0.00326 shs$3,000.0005/14/2025$0.00$0.00+200.00%$0.00$0.00326 shs$3,000.0005/13/2025$0.00$0.00$0.00$0.00607 shs$1,000.0005/12/2025$0.00$0.00$0.00$0.001,005 shs$1,000.0005/09/2025$0.00$0.00$0.00$0.002,650 shs$1,000.00 Get the Latest News and Ratings for EFTR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for eFFECTOR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/08/2025$0.00$0.00$0.00$0.002,264 shs$1,000.0005/07/2025$0.00$0.00$0.00$0.002,264 shs$1,000.0005/06/2025$0.00$0.00$0.00$0.001 shs$1,000.0005/05/2025$0.00$0.00$0.00$0.005,001 shs$1,000.0005/02/2025$0.00$0.00$0.00$0.005,001 shs$1,000.0005/01/2025$0.00$0.00$0.00$0.00103 shs$1,000.0004/30/2025$0.00$0.00$0.00$0.0063 shs$1,000.0004/29/2025$0.00$0.00$0.00$0.0023 shs$1,000.0004/28/2025$0.00$0.00$0.00$0.0023 shs$1,000.0004/25/2025$0.00$0.00$0.00$0.004,001 shs$1,000.0004/24/2025$0.00$0.00$0.00$0.004,001 shs$1,000.0004/23/2025$0.00$0.00$0.00$0.0020,991 shs$1,000.0004/22/2025$0.00$0.00$0.00$0.002,086 shs$1,000.00 Related Companies Ampio Pharmaceuticals Stock Price Chart Comera Life Sciences Stock Price Chart OncoSec Medical Stock Price Chart PaxMedica Stock Price Chart 180 Life Sciences Stock Price Chart 4D pharma Stock Price Chart Aesther Healthcare Acquisition Stock Price Chart Ainos Stock Price Chart Alvotech Stock Price Chart Atlantic Coastal Acquisition Corp. II Stock Price Chart Receive EFTR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for eFFECTOR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EFTR) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding eFFECTOR Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share eFFECTOR Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EFTR Stock Free EFTR Stock Alerts